VRS
KDNY

Virginia Retirement Systems’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Virginia Retirement Systems’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,900
Closed -$332K – 1264
2022
Q3 		$332K Buy
+16,900
New +$339K ﹤0.01% 921

Other funds holding KDNY

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Virginia Retirement Systems's KDNY Position: Q4 2022 in Review

Virginia Retirement Systems sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2022, closing a stake of 16,900 shares — an estimated $332K sold.

Virginia Retirement Systems first reported a position in KDNY in Q3 2022 and held it in 1 quarter. The position peaked at $332K in Q3 2022. 155 funds tracked by Wall St. Rank hold KDNY as of Q4 2022.

  • Virginia Retirement Systems reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Virginia Retirement Systems sold 16,900 Chinook Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $332K.
  • Virginia Retirement Systems first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Virginia Retirement Systems's Chinook Therapeutics, Inc. Common Stock position peaked at $332K in Q3 2022.
  • 155 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Virginia Retirement Systems's 13F filing for Q4 2022, filed 17 May 2023.